ITEM TYPE:
Journal Article
AUTHORS:
J. David Holcomb, MD
KEY POINTS:
- Helium plasma energy is delivered to the tissue in a bimodal fashion via thermal convection/conduction and an ionized helium radiofrequency bridge.
- Animal studies demonstrate greater skin tissue contraction for helium plasma versus nitrogen plasma, likely resulting from greater energy density for helium plasma.
- Clinical use of helium plasma for skin rejuvenation demonstrates significant skin tightening and rhytid reduction, high patient satisfaction, and manageable side effects/complications.
- Helium plasma skin regeneration may be safely performed concurrently with various surgical facial rejuvenation procedures but should be staged ideally before injectable soft tissue filler injections.
- Indications, contraindications, efficacy, and side effects/complications for helium plasma energy skin rejuvenation are similar to deep laser skin resurfacing treatments except that treatment must be avoided in patients with implanted electrical devices.
APYX® MEDICAL DISCLOSURES:
FINANCIAL & CONTENT DISCLOSURE
The authors declared no potential conflicts of interest with respect to the research, authorship, and publication of this article. No funding was received for this article. Drs DiBernardo, Bharti, and Kortesis are paid consultants for Apyx Medical, and Dr Duncan is a member of Apyx Medical’s Medical Advisory Board. The opinions contained herein are those of the authors and do not necessarily represent the official position or policies of Apyx Medical, Inc.
MANUFACTURING DISCLOSURE
Apyx Medical manufactures and owns the Renuvion®/J-Plasma® technology discussed in this article.
INDICATIONS FOR USE & INTENDED USE DISCLOSURES
- Renuvion Dermal Handpiece is indicated for dermatological procedures for the treatment of moderate to severe wrinkles and rhytides, limited to patients with Fitzpatrick skin types I, II, or III.
- Apyx Medical wants to present to you with current scientific discourse. Specific usage outside of the cleared indications may not be safe or effective.
RISKS
- Risks associated with the use of the Renuvion Dermal System include but are not limited to hypertrophic scarring, milia/acne, telangiectasia (spider veins), skin discoloration/ hypopigmentation, dormant infection reactivation, infection, bruising or bleeding. Warning: Application of more than one treatment pass in the perioral area, on the forehead, and along the jawline has been associated with hypertrophic scarring.
As with any procedure, individual results may vary. As with all energy devices there are inherent risks associated with its use, refer to the IFU for further information.
